0001493152-21-010524.txt : 20210505 0001493152-21-010524.hdr.sgml : 20210505 20210505161600 ACCESSION NUMBER: 0001493152-21-010524 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYNJELSEN SEAN CENTRAL INDEX KEY: 0001669976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38738 FILM NUMBER: 21893474 MAIL ADDRESS: STREET 1: C/O ETON PHARMACEUTICALS, INC. STREET 2: 21925 W FIELD PKWY #235 CITY: DEER PARK STATE: IL ZIP: 60010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7208 BUSINESS PHONE: (847) 787-7361 MAIL ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7208 4 1 ownership.xml X0306 4 2021-05-03 0 0001710340 Eton Pharmaceuticals, Inc. ETON 0001669976 BRYNJELSEN SEAN 21925 W FIELD PKWY, SUITE 235 DEER PARK IL 60010-7278 1 1 0 0 President & CEO Stock Option(Right to buy) 8.61 2021-05-03 4 A 0 245000 0.00 A 2031-05-03 Common Stock 245000 1185000 D The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2023. /s/ W. Wilson Troutman 2021-05-05